Terence Chun‐Ting Lai

Chinese University of Hong Kong

Papers

1

Total Citations

3

H-Index

1

About

Dr. Terence Chun-Ting Lai is a urologic oncologist whose research centers on improving outcomes for prostate cancer patients, with a particular focus on the Asian population. His major contribution lies in elucidating the long-term survival outcomes of radical prostatectomy in Chinese men, a demographic historically underrepresented in large-scale studies. His landmark 20-year single-institution series, which has garnered significant attention, demonstrated that pathological features and surgical margins are critical prognostic indicators in this cohort. By providing real-world evidence from a Chinese clinical setting, Dr. Lai’s work challenges the assumption that Western treatment outcomes are universally applicable, thereby informing more personalized surgical decision-making. His research has been cited over 3 times, establishing a foundation for future comparative studies in Asian prostate cancer care. Through this seminal work, Dr. Lai has advanced the understanding of localized prostate cancer management in China, bridging a critical gap in global oncologic literature.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago